We’ve all been there. You are at a party and someone asks, “So, what do you do?” Dr. Kirsch always found it hard to explain his career as a discovery scientist. He decided to write a book about it. The Drug Hunters: An Improbable Quest to Discover New Medicines is a colorful, fact-filled narrative history of the search for new medicines…Read More
Meet Kyle Bryant On our next episode of Improbable Developments we welcome Kyle Bryant of the Friedreich’s Ataxia Research Alliance (FARA) to discuss his journey as a patient with Friedreich’s Ataxia (FA), as an active patient leader, and in his job as a liaison between the FA community and researchers. After being diagnosed with FA…Read More
The science of drug discovery and development creates a rich landscape for all sorts of stories to unfold.
Each month we are going to talk to someone who was in the trenches of R&D and let them tell their story. We’ll be talking about medicines you may know and some that never saw the light of day.Read More
Salem Oaks’ portfolio of online courses is growing rapidly. Since last month, we launched two new modules in the R&D decision-making series, bringing the total to four. Check them out and see where we are going next!Read More
The fourth module in our series on Decision Making in Pharmaceutical Research and Development. focuses on the decisions required for Phase 1 Clinical Studies. The stakes are higher as people participate in the studies. These first studies establish a beachhead that will allow the team to learn more and more about the compound. It gets pretty exciting!Read More
At Patients as Partners, our panel spoke about HOPE and asked the audience to think about a few questions.
–What is the power of hope?
–How much is hope worth?
–How much value do you create each time you give or receive hope?
Healthcare is rapidly changing. Patients, their families, and their advocates are playing a bigger role in decision-making about their care. In addition, the biopharmaceutical industry is realizing that patients can make a valuable contribution to the entire R&D process. They are looking for patients (and others) who can influence the direction of research, the design,…Read More
The acorn has sprouted Salem Oaks has done a lot in the last year or so. When this company began it was just an idea. Over the last year, not only has the company grown, but projects are now under way and in action. We are actively gaining an understanding of the needs and…Read More
The moment was awkward. We had invited in a handful of patients who had the disease we were working to treat to our annual Development Team all-hands meeting. We wanted to learn from them and to be motivated by them. They poured their hearts out to us. They told us about their lives since the…Read More
Sometimes you get the chance to experience something that resets your expectations. The Salem Oaks team had the opportunity to attend the Rare Patient Advocacy Symposium in Philadelphia on May 19, 2018. The event was organized in partnership between Global Genes and the Orphan Disease Center at UPenn. Although I may have only recently jumped…Read More